India’s Himachal Pradesh state eyes foreign investment in bulk drugs – FiercePharma
0
India’s state of Himachal Pradesh, known as Asia’s pharmaceutical hub, is taking steps to make its bulk-drug industry more attractive to foreign and other investors, but finds attempting to do so a hard slog. The action, and that of other states, is considered key to reducing India’s reliance on imports of active pharmaceutical ingredients (APIs), mainly from China.
Read more – FiercePharma